Copyright © 2012 Kadiyala V. Ravindra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. L. Cendales, D. Granger, M. Henry et al., “Implementation of vascularized composite allografts in the United States: recommendations from the ASTS VCA Ad Hoc committee and the executive committee,” American Journal of Transplantation, vol. 11, no. 1, pp. 13–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
2. J. D. Scandling, S. Busque, S. Dejbakhsh-Jones et al., “Tolerance and chimerism after renal and hematopoietic-cell transplantation,” The New England Journal of Medicine, vol. 358, no. 4, pp. 362–368, 2008. View at Publisher · View at Google Scholar · View at Scopus
3. T. Kawai, A. B. Cosimi, T. R. Spitzer et al., “HLA-mismatched renal transplantation without maintenance immunosuppression,” The New England Journal of Medicine, vol. 358, no. 4, pp. 353–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
4. J. Leventhal, M. Abecassis, J. Miller, et al., “Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation,” Science Translational Medicine, vol. 4, Article ID 124ra28, 2012.
5. J. F. Markmann and T. Kawai, “The quest for transplantation tolerance: have we finally sipped from the cup?” Science Translational Medicine, vol. 4, Article ID 124fs5, 2012.
6. P. Petruzzo, M. Lanzetta, J. M. Dubernard et al., “The international registry on hand and composite tissue transplantation,” Transplantation, vol. 90, no. 12, pp. 1590–1594, 2010. View at Publisher · View at Google Scholar · View at Scopus
7. P. Petruzzo, M. Lanzetta, J. M. Dubernard et al., “The international registry on hand and composite tissue transplantation,” Transplantation, vol. 86, no. 4, pp. 487–492, 2008. View at Publisher · View at Google Scholar · View at Scopus
8. A. Sener, A. L. Tang, and D. L. Farber, “Memory T-cell predominance following T-Cell depletional therapy derives from homeostatic expansion of naive T cells,” American Journal of Transplantation, vol. 9, no. 11, pp. 2615–2623, 2009. View at Publisher · View at Google Scholar · View at Scopus
9. K. V. Ravindra, S. Wu, L. Bozulic, H. Xu, W. C. Breidenbach, and S. T. Ildstad, “Composite tissue transplantation: a rapidly advancing field,” Transplantation Proceedings, vol. 40, no. 5, pp. 1237–1248, 2008. View at Publisher · View at Google Scholar · View at Scopus
10. K. V. Ravindra, S. Wu, M. McKinney, H. Xu, and S. T. Ildstad, “Composite tissue allotransplantation: current challenges,” Transplantation Proceedings, vol. 41, no. 9, pp. 3519–3528, 2009. View at Publisher · View at Google Scholar · View at Scopus
11. K. V. Ravindra, H. Xu, and S. T. Ildstad, “Vascularized composite allotransplantation at a crossroad,” Transplantation Proceedings, vol. 43, no. 9, pp. 3501–3503, 2011.
12. B. J. Nankivell and S. I. Alexander, “Rejection of the kidney allograft,” The New England Journal of Medicine, vol. 363, no. 15, pp. 1451–1462, 2010. View at Publisher · View at Google Scholar · View at Scopus
13. J. E. Murray, “Organ transplantation (skin, kidney, heart) and the plastic surgeon,” Plastic and Reconstructive Surgery, vol. 47, no. 5, pp. 425–431, 1971. View at Scopus
14. W. P. A. Lee, M. J. Yaremchuk, Y. C. Pan, M. A. Randolph, C. M. Tan, and A. J. Weiland, “Relative antigenicity of components of a vascularized limb allograft,” Plastic and Reconstructive Surgery, vol. 87, no. 3, pp. 401–411, 1991. View at Scopus
15. L. Brent, J. Brown, and P. B. Medawar, “Skin transplantation immunity in relation to hypersensitivity,” The Lancet, vol. 272, no. 7046, pp. 561–564, 1958. View at Scopus
16. O. Thaunat, L. Badet, A. El-Jaafari, J. Kanitakis, J. M. Dubernard, and E. Morelon, “Composite tissue allograft extends a helping hand to transplant immunologists,” American Journal of Transplantation, vol. 6, no. 10, pp. 2238–2242, 2006. View at Publisher · View at Google Scholar · View at Scopus
17. M. Siemionow and S. Nasir, “Impact of donor bone marrow on survival of composite tissue allografts,” Annals of Plastic Surgery, vol. 60, no. 4, pp. 455–462, 2008. View at Publisher · View at Google Scholar · View at Scopus
18. D. K. Granger, W. C. Briedenbach, D. J. Pidwell, J. W. Jones, L. A. Baxter-Lowe, and C. L. Kaufman, “Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand,” Transplantation, vol. 74, no. 11, pp. 1624–1630, 2002. View at Publisher · View at Google Scholar · View at Scopus
19. J. Kanitakis, D. Jullien, A. Claudy, J. P. Revillard, and J. M. Dubemard, “Microchimerism in a human hand allograft,” The Lancet, vol. 354, no. 9192, pp. 1820–1821, 1999. View at Scopus
20. T. M. Fishbein, “Intestinal transplantation,” The New England Journal of Medicine, vol. 361, no. 10, pp. 946–1008, 2009. View at Publisher · View at Google Scholar · View at Scopus
21. T. Martinu, D. F. Chen, and S. M. Palmer, “Acute rejection and humoral sensitization in lung transplant recipients,” Proceedings of the American Thoracic Society, vol. 6, no. 1, pp. 54–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
22. T. Hautz, B. Zelger, J. Grahammer et al., “Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation,” American Journal of Transplantation, vol. 10, no. 5, pp. 1200–1209, 2010. View at Publisher · View at Google Scholar · View at Scopus
23. L. C. Cendales, A. D. Kirk, J. M. Moresi, P. Ruiz, and D. E. Kleiner, “Composite tissue allotransplantation: classification of clinical acute skin rejection,” Transplantation, vol. 81, no. 3, pp. 418–422, 2006. View at Publisher · View at Google Scholar · View at Scopus
24. S. Schneeberger, V. S. Gorantla, R. P. Van Riet et al., “Atypical acute rejection after hand transplantation,” American Journal of Transplantation, vol. 8, no. 3, pp. 688–696, 2008. View at Publisher · View at Google Scholar · View at Scopus
25. L. C. Cendales, J. Kanitakis, S. Schneeberger et al., “The Banff 2007 working classification of skin-containing composite tissue allograft pathology,” American Journal of Transplantation, vol. 8, no. 7, pp. 1396–1400, 2008. View at Publisher · View at Google Scholar · View at Scopus
26. L. Landin, P. C. Cavadas, J. Ibanez, I. Roger, and F. Vera-Sempere, “CD3+-mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab,” Transplantation, vol. 87, no. 5, pp. 776–781, 2009.
27. J. V. Unadkat, S. Schneeberger, E. H. Horibe et al., “Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation,” American Journal of Transplantation, vol. 10, no. 2, pp. 251–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
28. C. L. Kaufman, R. Ouseph, B. Blair, et al., “Graft vasculopathy in clinical hand transplantation,” American Journal of Transplantation, vol. 12, no. 4, pp. 1004–1016, 2012.
29. M. Siemionow and C. Ozturk, “An update on facial transplantation cases performed between 2005 and 2010,” Plastic and Reconstrictive Surgery, vol. 128, no. 6, pp. 707e–720e, 2011.
30. T. Hautz, G. Brandacher, T. O. Engelhardt, et al., “How reconstructive transplantation is different from organ transplantation—and how it is not,” Transplantation Proceedings, vol. 43, no. 9, pp. 3504–3511, 2011.
31. C. R. Gordon, W. Abouhassan, and R. K. Avery, “What is the true significance of donor-related cytomegalovirus transmission in the setting of facial composite tissue allotransplantation?” Transplantation Proceedings, vol. 43, no. 9, pp. 3516–3520, 2011.
32. M. Siemionow and C. Ozturk, “Face transplantation: outcomes, concerns, controversies, and future directions,” Journal of Craniofacial Surgery, vol. 23, no. 1, pp. 254–259, 2012.
33. E. G. Jacquet, C. L. Schanie, I. Fugier-Vivier, S. S. Willer, and S. T. Ildstad, “Facilitating cells as a venue to establish mixed chimerism and tolerance,” Pediatric Transplantation, vol. 7, no. 5, pp. 348–357, 2003. View at Publisher · View at Google Scholar · View at Scopus
34. A. B. Farris, D. Taheri, T. Kawai et al., “Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts,” American Journal of Transplantation, vol. 11, no. 7, pp. 1464–1477, 2011. View at Publisher · View at Google Scholar · View at Scopus
35. G. Brandacher, J. Grahammer, R. Sucher, and W. P. Lee, “Animal models for basic and translational research in reconstructive transplantation,” Birth Defects Research C, vol. 96, no. 1, pp. 39–50, 2012.
36. R. D. Foster and T. Liu, “Orthotopic hindlimb transplantation in the mouse,” Journal of Reconstructive Microsurgery, vol. 19, no. 1, pp. 49–52, 2003. View at Scopus
37. S. Tuffaha, M. Quigley, T. Ng et al., “The effect of chondroitinase on nerve regeneration following composite tissue allotransplantation,” Journal of Hand Surgery, vol. 36, no. 9, pp. 1447–1452, 2011. View at Publisher · View at Google Scholar · View at Scopus
38. A. E. Ulusal, B. G. Ulusal, L. M. Hung, and F. C. Wei, “Temporary assisting suspension suture technique for successful microvascular anastomosis of extremely small and thin walled vessels for mice transplantation surgery,” Plastic and Reconstructive Surgery, vol. 116, no. 5, pp. 1438–1441, 2005. View at Publisher · View at Google Scholar · View at Scopus
39. R. Sucher, C. H. Lin, R. Zanoun et al., “Mouse hind limb transplantation: a new composite tissue allotransplantation model using nonsuture supermicrosurgery,” Transplantation, vol. 90, no. 12, pp. 1374–1380, 2010. View at Publisher · View at Google Scholar · View at Scopus
40. R. Sucher, C. H. Lin, R. Oberhuber, et al., “Hemiface allotransplantation in the mouse,” Plastic and Reconstructive Surgery, vol. 129, no. 4, pp. 867–870, 2012.
41. B. G. Ulusal, A. E. Ulusal, and F. C. Wei, “Groin region as recipient site for experimental composite tissue allotransplantation and a rare anatomical variation of femoral vein,” Plastic and Reconstructive Surgery, vol. 119, no. 1, pp. 447–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
42. A. A. L. Barone, D. A. Leonard, R. Torabi, et al., “The gracilis myocutaneous free flap in swine: an advantageous preclinical model for vascularized composite allograft transplantation research,” Microsurgery. In press. View at Publisher · View at Google Scholar
43. C. Y. Villamaria, T. D. Rasmussen, J. R. Spencer, S. Patel, and M. R. Davis, “Microvascular porcine model for the optimization of vascularized composite tissue transplantation,” Journal of Surgical Research. In press.
44. D. Yu, Q. Li, S. Zheng, H. Wang, and Q. Liu, “Some results of our research on composite facial allograft transplantation in dogs,” Transplantation Proceedings, vol. 42, no. 5, pp. 1953–1955, 2010. View at Publisher · View at Google Scholar · View at Scopus
45. Z. Shengwu, L. Qingfeng, J. Hao et al., “Developing a canine model of composite facial/scalp allograft transplantation,” Annals of Plastic Surgery, vol. 59, no. 2, pp. 185–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
46. M. Siemionow and A. Klimczak, “Advances in the development of experimental composite tissue transplantation models,” Transplant International, vol. 23, no. 1, pp. 2–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
47. R. N. Barth, R. Bluebond-Langner, A. Nam et al., “Facial subunit composite tissue allografts in nonhuman primates: I. Technical and immunosuppressive requirements for prolonged graft Survival,” Plastic and Reconstructive Surgery, vol. 123, no. 2, pp. 493–501, 2009. View at Publisher · View at Google Scholar · View at Scopus
48. W. P. A. Lee, J. P. Rubin, J. L. Bourget et al., “Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens,” Plastic and Reconstructive Surgery, vol. 107, no. 6, pp. 1482–1490, 2001. View at Scopus
49. H. Pan, K. Zhao, L. Wang et al., “Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation,” Journal of Surgical Research, vol. 160, no. 2, pp. 315–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
50. S. T. Ildstad and D. H. Sachs, “Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of alllografts or xenografts,” Nature, vol. 307, no. 5947, pp. 168–170, 1984. View at Scopus
51. D. N. Rahhal, H. Xu, W. C. Huang et al., “Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone,” Transplantation, vol. 88, no. 6, pp. 773–781, 2009. View at Publisher · View at Google Scholar · View at Scopus
52. P. Yu, S. Xiong, Q. He et al., “Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts,” Immunology, vol. 127, no. 4, pp. 500–511, 2009. View at Publisher · View at Google Scholar · View at Scopus
53. S. T. Ildstad, S. M. Wren, and J. A. Bluestone, “Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance,” Journal of Experimental Medicine, vol. 162, no. 1, pp. 231–244, 1985. View at Scopus
54. M. Sykes and D. H. Sachs, “Mixed allogeneic chimerism as an approach to transplantation tolerance,” Immunology Today, vol. 9, no. 1, pp. 23–27, 1988. View at Scopus
55. Y. L. Colson, R. A. Tripp, P. C. Doherty et al., “Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: functional restriction to host MHC,” Journal of Immunology, vol. 160, no. 8, pp. 3790–3796, 1998. View at Scopus
56. Y. L. Colson, S. M. Wren, M. J. Schuchert et al., “A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers,” Journal of Immunology, vol. 155, no. 9, pp. 4179–4188, 1995. View at Scopus
57. Y. L. Colson, H. Li, S. S. Boggs, K. D. Patrene, P. C. Johnson, and S. T. Ildstad, “Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach,” Journal of Immunology, vol. 157, no. 7, pp. 2820–2829, 1996. View at Scopus
58. H. Xu, B. G. Exner, D. E. Cramer, M. K. Tanner, Y. M. Mueller, and S. T. Ildstad, “CD8₊, αβ-TCR₊, and γδTCR₊ cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow,” Journal of Immunology, vol. 168, no. 4, pp. 1636–1643, 2002. View at Scopus
59. H. Xu, P. M. Chilton, Y. Huang, C. L. Schanie, and S. T. Ildstad, “Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism,” Journal of Immunology, vol. 172, no. 3, pp. 1463–1471, 2004. View at Scopus
60. Y. Sharabi and D. H. Sachs, “Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen,” Journal of Experimental Medicine, vol. 169, no. 2, pp. 493–502, 1989. View at Scopus
61. Y. Tomita, A. Khan, and M. Sykes, “Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen,” Journal of Immunology, vol. 153, no. 3, pp. 1087–1098, 1994. View at Scopus
62. L. Luznik, P. V. O'Donnell, H. J. Symons et al., “HLA-Haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide,” Biology of Blood and Marrow Transplantation, vol. 14, no. 6, pp. 641–650, 2008. View at Publisher · View at Google Scholar · View at Scopus
63. H. Xu, Z. Zhu, Y. Huang, et al., “Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning,” Transplantation, vol. 93, no. 5, pp. 469–476, 2012.
64. R. D. Foster, S. Pham, S. Li, and A. Aitouche, “Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade,” Transplantation, vol. 76, no. 6, pp. 988–994, 2003. View at Publisher · View at Google Scholar · View at Scopus
65. K. A. Prabhune, V. S. Gorantla, G. Perez-Abadia et al., “Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model,” Transplantation, vol. 76, no. 11, pp. 1548–1555, 2003. View at Publisher · View at Google Scholar · View at Scopus
66. V. S. Gorantla, K. A. Prabhune, G. Perez-Abadia et al., “Composite tissue allotransplantation in chimeric hosts: Part I. Prevention of graft-versus-host disease,” Transplantation, vol. 75, no. 7, pp. 922–932, 2003. View at Scopus
67. T. H. Tung, S. E. Mackinnon, and T. Mohanakumar, “Combined treatment with CD40 costimulation blockade, T-cell depletion, low-dose irradiation, and donor bone marrow transfusion in limb allograft survival,” Annals of Plastic Surgery, vol. 55, no. 5, pp. 512–518, 2005. View at Publisher · View at Google Scholar · View at Scopus
68. J. Y. Lin, F. C. Tsai, C. G. Wallace, W. C. Huang, F. C. Wei, and S. K. Liao, “Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation,” Journal of Surgical Research. In press.
69. S. M. Pham, R. L. Kormos, B. G. Hattler et al., “A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results,” Journal of Thoracic and Cardiovascular Surgery, vol. 111, no. 4, pp. 764–772, 1996. View at Publisher · View at Google Scholar · View at Scopus
70. S. M. Pham, A. S. Rao, A. Zeevi et al., “A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results,” Journal of Thoracic and Cardiovascular Surgery, vol. 119, no. 4, part 1, pp. 673–681, 2000. View at Scopus
71. T. E. Starzl, “Chimerism and tolerance in transplantation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, supplement 2, pp. 14607–14614, 2004. View at Publisher · View at Google Scholar · View at Scopus
72. T. E. Starzl and R. M. Zinkernagel, “Transplantation tolerance from a historical perspective,” Nature Reviews Immunology, vol. 1, no. 3, pp. 233–239, 2001. View at Scopus
73. S. Janczewska, A. Ziolkowska, M. Durlik, W. L. Olszewski, and B. Lukomska, “Fast lymphoid reconstitution after vascularized bone marrow transplatation in lethally irradiated rats,” Transplantation, vol. 68, no. 2, pp. 201–209, 1999. View at Publisher · View at Google Scholar · View at Scopus
74. A. W. Bingaman, S. Y. Waitze, D. Z. Alexander et al., “Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning,” Transplantation, vol. 69, no. 12, pp. 2491–2496, 2000. View at Scopus
75. O. Gurevitch, T. B. Prigozhina, T. Pugatsch, and S. Slavin, “Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment,” Transplantation, vol. 68, no. 9, pp. 1362–1368, 1999. View at Scopus
76. B. Yazdi, M. P. Patel, R. Ramsamooj et al., “Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients,” Transplantation Proceedings, vol. 23, no. 1, part 1, pp. 739–740, 1991. View at Scopus
77. R. Llull, N. Murase, Q. Ye et al., “Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction,” Transplantation Proceedings, vol. 27, no. 1, pp. 164–165, 1995. View at Scopus
78. S. F. Santiago, W. de Faria, T. F. Khan, et al., “Heterotopic sternum transplant in rats: a new model of a vascularized bone marrow transplantation,” Microsurgery, vol. 19, no. 7, pp. 330–334, 1999.
79. H. Suzuki, N. Patel, M. Matthews, A. J. DelRossi, E. J. Doolin, and C. W. Hewitt, “Vascularized bone marrow transplantation: a new surgical approach using isolated femoral bone/bone marrow,” Journal of Surgical Research, vol. 89, no. 2, pp. 176–183, 2000. View at Publisher · View at Google Scholar · View at Scopus
80. I. Yazici, K. Carnevale, A. Klimczak, and M. Siemionow, “A new rat model of maxilla allotransplantation,” Annals of Plastic Surgery, vol. 58, no. 3, pp. 338–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
81. S. Nasir, A. Klimczak, E. Sonmez, M. Bozkurt, S. Gibson, and M. Siemionow, “New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap,” Transplant International, vol. 23, no. 1, pp. 90–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
82. B. Chen, H. Xu, D. R. Corbin, and S. T. Ildstad, Delayed Tolerance Induction in Recipients of a Prior vascular Composite Allotransplant, American Transplant Congress, Boston, Mass, USA, 2012.
83. Y. Yamada, S. Boskovic, A. Aoyama, et al., “Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates,” American Journal of Transplantation, vol. 12, no. 2, pp. 330–340, 2012.
84. I. Koyama, O. Nadazdin, S. Boskovic et al., “Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft,” American Journal of Transplantation, vol. 7, no. 5, pp. 1055–1061, 2007. View at Publisher · View at Google Scholar · View at Scopus
85. H. Xu, P. M. Chilton, M. K. Tanner et al., “Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients,” Blood, vol. 108, no. 10, pp. 3611–3619, 2006. View at Publisher · View at Google Scholar · View at Scopus
86. P. A. Taylor, C. J. Lees, J. M. Wilson et al., “Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions,” Blood, vol. 100, no. 9, pp. 3400–3407, 2002. View at Publisher · View at Google Scholar · View at Scopus
87. P. A. Taylor, M. J. Ehrhardt, M. M. Roforth et al., “Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients,” Blood, vol. 109, no. 3, pp. 1307–1315, 2007. View at Publisher · View at Google Scholar · View at Scopus
88. C. Gibbons and M. Sykes, “Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism,” Immunological Reviews, vol. 223, no. 1, pp. 334–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
89. H. Xu, P. M. Chilton, Y. Huang, C. L. Schanie, J. Yan, and S. T. Ildstad, “Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation,” Transplantation, vol. 83, no. 7, pp. 954–963, 2007. View at Publisher · View at Google Scholar · View at Scopus
90. N. Pilat, U. Baranyi, C. Klaus et al., “Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning,” American Journal of Transplantation, vol. 10, no. 4, pp. 751–762, 2010. View at Publisher · View at Google Scholar · View at Scopus
91. A. Bernard, S. Coitot, A. Brémont, and G. Bernard, “T and B cell cooperation: a dance of life and death,” Transplantation, vol. 79, no. 3, pp. S8–S11, 2005. View at Publisher · View at Google Scholar · View at Scopus
92. M. K. Slifka and R. Ahmed, “Long-lived plasma cells: a mechanism for maintaining persistent antibody production,” Current Opinion in Immunology, vol. 10, no. 3, pp. 252–258, 1998. View at Publisher · View at Google Scholar · View at Scopus
93. H. Xu, J. Yan, Y. Huang et al., “Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization,” Blood, vol. 111, no. 6, pp. 3266–3275, 2008. View at Publisher · View at Google Scholar · View at Scopus
94. M. Siemionow, A. Klimczak, S. Unal, G. Agaoglu, and K. Carnevale, “Hematopoietic stem cell engraftment and seeding permits multi-lymphoid chimerism in vascularized bone marrow transplants,” American Journal of Transplantation, vol. 8, no. 6, pp. 1163–1176, 2008. View at Publisher · View at Google Scholar · View at Scopus
95. J. Kurtz, T. Wekerle, and M. Sykes, “Tolerance in mixed chimerism—a role for regulatory cells?” Trends in Immunology, vol. 25, no. 10, pp. 518–523, 2004. View at Publisher · View at Google Scholar · View at Scopus
96. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, “Regulatory T cells and immune tolerance,” Cell, vol. 133, no. 5, pp. 775–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
97. L. D. Bozulic, Y. Wen, H. Xu, and S. T. Ildstad, “Evidence that foxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants,” Transplantation, vol. 91, no. 8, pp. 908–915, 2011. View at Publisher · View at Google Scholar · View at Scopus
98. S. Bunnag, K. Allanach, G. S. Jhangri et al., “FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes,” American Journal of Transplantation, vol. 8, no. 7, pp. 1423–1433, 2008. View at Publisher · View at Google Scholar · View at Scopus
99. A. Eljaafari, L. Badet, J. Kanitakis et al., “Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation,” Transplantation, vol. 82, no. 12, pp. 1764–1768, 2006. View at Publisher · View at Google Scholar · View at Scopus
100. T. Hautz, G. Brandacher, B. Zelger et al., “Indoleamine 2,3-Dioxygenase and Foxp3 expression in skin rejection of human hand allografts,” Transplantation Proceedings, vol. 41, no. 2, pp. 509–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
101. L. F. Lu, E. F. Lind, D. C. Gondek et al., “Mast cells are essential intermediaries in regulatory T-cell tolerance,” Nature, vol. 442, no. 7106, pp. 997–1002, 2006. View at Publisher · View at Google Scholar · View at Scopus
102. D. W. Mathes, B. Hwang, S. S. Graves, et al., “Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras,” Transplantation, vol. 92, no. 12, pp. 1301–1308, 2011.
103. C. Fondi, C. Nozzoli, S. Benemei et al., “Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response,” Biology of Blood and Marrow Transplantation, vol. 15, no. 8, pp. 938–947, 2009. View at Publisher · View at Google Scholar · View at Scopus
104. D. Golshayan, J. C. Wyss, C. W. Abulker et al., “Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action,” International Immunopharmacology, vol. 9, no. 6, pp. 683–688, 2009. View at Publisher · View at Google Scholar · View at Scopus
105. S. K. Chauhan, D. R. Saban, H. K. Lee, and R. Dana, “Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation,” Journal of Immunology, vol. 182, no. 1, pp. 148–153, 2009. View at Scopus
106. A. Hoerning, S. Kohler, C. Jun, et al., “Peripherally circulating CD4(+) FOXP3(+) CXCR3(+) T regulatory cells correlate with renal allograft function,” Scandanavian Journal of Immunology, vol. 76, no. 3, pp. 320–328. View at Publisher · View at Google Scholar